What monitoring and supportive care should be provided for a patient with suspected diphenhydramine (Benadryl) overdose?

Monitoring and Supportive Care for Diphenhydramine (Benadryl) Overdose

For suspected diphenhydramine overdose, immediately assess airway-breathing-circulation, establish continuous cardiac monitoring with serial ECGs to track QRS duration, monitor vital signs continuously, secure IV access, and prepare to treat life-threatening complications including seizures and wide-complex dysrhythmias with benzodiazepines and sodium bicarbonate respectively. 1

Initial Assessment and Stabilization

Stop any ongoing diphenhydramine administration immediately and assess ABCs (airway, breathing, circulation). 1 The priority is maintaining adequate ventilation and perfusion, as diphenhydramine overdose presents with anticholinergic toxicity affecting multiple organ systems plus sodium channel blockade causing cardiac toxicity similar to tricyclic antidepressants. 1

Immediate Monitoring Parameters

• Continuous cardiac monitoring with serial 12-lead ECGs to track QRS duration—widening beyond 100 ms indicates severe sodium channel blockade requiring immediate intervention 1, 2
• Continuous vital sign monitoring including blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature 1
• Neurological status assessment every 15-30 minutes initially, watching for altered consciousness, seizures, agitation, hallucinations, or paradoxical excitation (especially in children) 1, 3
• Core temperature monitoring for hyperthermia from anticholinergic effects 3

Secure Vascular Access and Position Patient

• Establish at least one large-bore IV line for fluid resuscitation and medication administration 1
• Position patient appropriately to maintain airway patency and prevent aspiration 1
• Administer supplemental oxygen as needed to maintain SpO2 >94% 1

Specific Life-Threatening Complications and Their Management

Cardiac Toxicity: QRS Prolongation and Wide-Complex Dysrhythmias

For QRS prolongation >100 ms or wide-complex dysrhythmias, administer sodium bicarbonate 1-2 mEq/kg IV bolus immediately. 1 This is the most critical cardiac intervention, as diphenhydramine blocks sodium channels identically to tricyclic antidepressants. 1, 4

• Repeat sodium bicarbonate boluses until QRS narrows to <100 ms 1, 4
• Target serum pH of 7.50-7.55 with sodium bicarbonate therapy 4
• Monitor serial electrolytes throughout treatment for hypokalemia, hypochloremia, hypernatremia, and alkalemia—common complications of bicarbonate therapy 2

Common pitfall: Physostigmine is absolutely contraindicated in the presence of QRS widening or any cardiac conduction abnormality, as it can precipitate asystole. 3, 4 Despite being an anticholinergic antidote, it should be reserved only for pure anticholinergic toxicity without cardiac involvement and only administered in-hospital. 3

Seizures and Status Epilepticus

For seizures or severe agitation, administer benzodiazepines as first-line therapy. 1 Diphenhydramine can cause status epilepticus, though this is uncommon. 4

• Lorazepam 2-4 mg IV (0.1 mg/kg in children) or midazolam 5-10 mg IM/IV (0.2 mg/kg in children) 4
• Repeat benzodiazepine dosing every 3-5 minutes if seizures continue 4
• Prepare for endotracheal intubation and propofol infusion if status epilepticus develops and is refractory to benzodiazepines 4
• EMS personnel may administer benzodiazepines for agitation or seizures if authorized by medical direction 3

Hypotension and Cardiovascular Collapse

For hypotension, begin with IV fluid boluses (20 mL/kg crystalloid), then escalate to vasopressors if unresponsive. 1

• Dopamine 5-20 mcg/kg/min or norepinephrine 0.05-0.5 mcg/kg/min titrated to maintain mean arterial pressure >65 mmHg 1
• Continuous hemodynamic monitoring is essential when vasopressors are required 1

Respiratory Depression

Monitor closely for respiratory depression, particularly if other sedatives were co-ingested. 2 This is a critical monitoring parameter throughout the observation period.

• Prepare for bag-mask ventilation and potential endotracheal intubation 3
• Maintain airway patency and adequate oxygenation/ventilation as the absolute priority 3

Advanced/Refractory Treatment Options

Intravenous Fat Emulsion (IFE) Therapy

For cardiovascular collapse refractory to sodium bicarbonate and standard supportive measures, consider 20% lipid emulsion 1.5 mL/kg IV bolus over 1 minute, followed by 0.25 mL/kg/min infusion. 5 This is supported by case reports showing rapid improvement in patients with life-threatening diphenhydramine toxicity unresponsive to other therapies, though it remains an adjunctive measure. 5, 6

Extracorporeal Removal

Charcoal hemoperfusion may be considered for massive overdoses (>20 mg/kg) with cardiovascular collapse refractory to all standard measures. 7 One case report documented survival after 16 g ingestion (approximately 20 mg/kg) with rapid ECG improvement within 40 minutes of initiating charcoal hemoperfusion. 7 However, this is reserved for extreme cases in centers with this capability. 7

Observation Period and Disposition Criteria

Minimum Observation Requirements

Patients must be observed in a healthcare setting until anticholinergic toxicity resolves, vital signs normalize, and risk of recurrent symptoms is low. 2

• Asymptomatic patients with oral ingestion: Observe minimum 4 hours post-ingestion before considering discharge 3
• Symptomatic patients: Observe until complete resolution of symptoms, typically requiring admission 3
• Severe overdoses (cardiac arrest, status epilepticus): Require 2-3 days of intensive monitoring 2

Signs of Clinical Improvement

Monitor for these key indicators of recovery: 2

• Mental status improvement from confusion/agitation to alert and oriented
• Vital sign normalization including heart rate <100 bpm, blood pressure stable without pressors, temperature <38°C
• QRS duration narrowing to <100 ms on serial ECGs
• Cessation of seizure activity
• Neurological recovery should be evident by hospital day 2 in most cases with appropriate management 2

Absolute Contraindications to Discharge

Do not discharge or downgrade care if any of the following persist: 2

• Ongoing seizure activity or altered mental status beyond mild drowsiness
• Persistent hypotension requiring vasopressor support
• Respiratory depression requiring mechanical ventilation
• QRS duration >100 ms
• New onset urinary retention or severe constipation (anticholinergic effects)

Special Population Considerations

Pediatric Patients

Children may exhibit paradoxical excitation rather than sedation and require closer monitoring for respiratory depression. 2 Children <6 years ingesting ≥7.5 mg/kg should be referred to an emergency department. 3

Elderly Patients

Monitor elderly patients more closely for prolonged confusion, delirium, and falls risk even after apparent recovery, as anticholinergic effects persist longer in this population. 2

Laboratory and Diagnostic Monitoring

Essential Laboratory Tests

• Serial electrolytes (sodium, potassium, chloride, bicarbonate) every 2-4 hours during active treatment 2
• Arterial blood gas if administering sodium bicarbonate to monitor pH 4
• Serum diphenhydramine level if available (therapeutic 9-120 ng/mL; toxic >500 ng/mL) 4
• Renal function (creatinine, BUN) as marker of improvement 2
• Urinalysis to monitor for urinary retention 2

Cardiac Monitoring

• Serial 12-lead ECGs every 1-2 hours until QRS <100 ms and stable 1, 2
• Continuous telemetry throughout observation period 1

Treatments to Avoid

Do NOT induce emesis or administer activated charcoal en route to the emergency department due to risk of rapid loss of consciousness or seizures. 3 Activated charcoal may be considered in-hospital within 1 hour of ingestion if airway is protected, but this window is often missed. 3

Do NOT administer physostigmine if QRS widening, cardiac conduction abnormalities, or seizures are present. 3, 4 Physostigmine should be reserved for hospital administration only in cases of pure anticholinergic toxicity without cardiac involvement. 3